Net Income per Share (Tables)

3 Months Ended

Mar. 31, 2021

The following table presents the calculation of basic and diluted net income per share (in thousands, except per share information):


	Three Months Ended March 31,
	2021		2020
Net income	$	13,593	$	8,974
Basic:
Weighted-average shares of common stock outstanding	31,864		31,637
Shares used in computing basic net income per share	31,864		31,637
Effect of dilutive securities:
Restricted stock subject to vesting	448		529
Shares issuable for acquisition consideration (1)	246		181
Shares issuable for conversion of convertible senior notes	433		529
Shares issuable for exercise of warrants	24		—
Shares used in computing diluted net income per share	33,015		32,876

Basic net income per share	$	0.43	$	0.28
Diluted net income per share	$	0.41	$	0.27

(1)For the three months ended March 31, 2021, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon Solutions Incorporated and certain related entities (collectively, “Zeon”); (ii) the Asset Purchase Agreement with MedTouch LLC (“MedTouch”); (iii) the Asset Purchase Agreement with Catalyst Networks, Inc. (“Brainjocks”); and (iv) the Stock Purchase Agreement with the shareholders of Productora de Software S.A.S. (“PSL”), as part of the consideration. For the three months ended March 31, 2020, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with RAS & Associates, LLC (“RAS”); (ii) the Asset Purchase Agreement with Zeon; (iii) the Asset Purchase Agreement with Stone Temple Consulting Corporation (“Stone Temple”); (iv) the Asset Purchase Agreement with Sundog Interactive, Inc. (“Sundog”); (v) the Asset Purchase Agreement with MedTouch; and (vi) the Asset Purchase Agreement with Brainjocks, as part of the consideration.

Antidilutive securities excluded from computation of earnings per share

The number of anti-dilutive securities not included in the calculation of diluted net income per share were as follows (in thousands):


	Three Months Ended March 31,
	2021	2020
Restricted stock subject to vesting	—	69

Warrants related to the issuance of convertible senior notes	4,451	3,823
Total anti-dilutive securities	4,451	3,892